X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-17 | NAUT | Nautilus Biotechnology, Inc. | Godwin Mary E. | SVP, Operations | S - Sale+OE | $2.85 | -35,000 | 0 | -100% | -$99,869 | |||||
| M | 2024-09-16 | OMIC | Singular Genomics Systems, Inc. | Tang Kevin | 10% | P - Purchase | $14.75 | +122,416 | 372,000 | +49% | +$1,806,220 | |||||
| D | 2024-09-15 | OMIC | Singular Genomics Systems, Inc. | Spaventa Andrew | CEO | S - Sale+OE | $12.38 | -175 | 140,685 | 0% | -$2,167 | |||||
2024-08-20 | QTRX | Quanterix Corp | Walt David R | Dir | P - Purchase | $13.29 | +47,000 | 1,487,342 | +3% | +$624,630 | ||||||
2024-09-16 | PACB | Pacific Biosciences of California, Inc. | Henry Christian O | See Remarks | S - Sale | $1.75 | -98,907 | 2,497,763 | -4% | -$172,692 | ||||||
| D | 2024-09-06 | BIOBI | Bio-Rad Laboratories, Inc. | Last Andrew J. | EVP, COO | S - Sale+OE | $329.94 | -3,000 | 7,559 | -28% | -$989,815 | |||||
| M | 2024-09-05 | TLIS | Talis Biomedical Corp | Leonard Braden Michael | 10% | P - Purchase | $1.47 | +30,100 | 248,702 | +14% | +$44,240 | |||||
2024-09-05 | AVTR | Avantor, Inc. | Eck Steven W | SVP, Chief Accounting Officer | S - Sale | $25.06 | -3,525 | 29,544 | -11% | -$88,337 | ||||||
2024-09-03 | TLIS | Talis Biomedical Corp | Leonard Braden Michael | 10% | P - Purchase | $4.00 | +500 | 218,602 | 0% | +$2,000 | ||||||
| D | 2024-09-04 | BIOBI | Bio-Rad Laboratories, Inc. | Barry James | EVP, Pres, LSG | S - Sale+OE | $330.50 | -623 | 147 | -81% | -$205,898 | |||||
2024-08-30 | TLIS | Talis Biomedical Corp | Leonard Braden Michael | 10% | P - Purchase | $4.25 | +151 | 218,602 | 0% | +$642 | ||||||
2024-08-27 | LAB | Standard Biotools Inc. | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $2.19 | +250,000 | 74,036,109 | 0% | +$546,750 | ||||||
| M | 2024-08-26 | TLIS | Talis Biomedical Corp | Leonard Braden Michael | 10% | P - Purchase | $3.90 | +14,382 | 217,951 | +7% | +$56,137 | |||||
| M | 2024-08-23 | HLTH | Cue Health Inc. | Tarsadia Capital, LLC | 10% | S - Sale | $0.00 | -18,302,244 | 3,613,413 | -84% | -$1,068 | |||||
| M | 2024-08-22 | LAB | Standard Biotools Inc. | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $2.06 | +750,000 | 127,411,930 | +1% | +$1,546,237 | |||||
2024-08-22 | TXG | 10X Genomics, Inc. | Saxonov Serge | CEO | S - Sale | $22.53 | -6,749 | 1,119,184 | -1% | -$152,053 | ||||||
2024-08-22 | TXG | 10X Genomics, Inc. | Hindson Benjamin J. | See Remarks | S - Sale | $22.53 | -4,351 | 345,704 | -1% | -$98,027 | ||||||
2024-08-22 | TXG | 10X Genomics, Inc. | McAnear Justin J. | Former Chief Financial Officer | S - Sale | $22.53 | -2,961 | 143,242 | -2% | -$66,710 | ||||||
2024-08-22 | A | Agilent Technologies, Inc. | McDonnell Padraig | Pres, CEO | S - Sale | $145.00 | -1,958 | 24,118 | -8% | -$283,910 | ||||||
| M | 2024-08-19 | LAB | Standard Biotools Inc. | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $1.88 | +1,250,000 | 73,036,109 | +2% | +$2,351,875 | |||||
2024-08-20 | EYPT | Eyepoint Pharmaceuticals, Inc. | Dicicco Wendy F | Dir | P - Purchase | $7.79 | +2,567 | 9,967 | +35% | +$19,997 | ||||||
2024-08-21 | EYPT | Eyepoint Pharmaceuticals, Inc. | Ando Goran | Dir | P - Purchase | $7.95 | +5,000 | 13,150 | +61% | +$39,750 | ||||||
2024-08-19 | EYPT | Eyepoint Pharmaceuticals, Inc. | Zaderej Karen L. | Dir | P - Purchase | $7.98 | +12,500 | 16,500 | +313% | +$99,750 | ||||||
2024-08-19 | PACB | Pacific Biosciences of California, Inc. | Eidel Jeff | See Remarks | S - Sale | $1.59 | -26,760 | 869,938 | -3% | -$42,602 | ||||||
2024-08-16 | PACB | Pacific Biosciences of California, Inc. | Van Oene Mark | See Remarks | S - Sale | $1.66 | -38,011 | 1,630,815 | -2% | -$63,174 | ||||||
2024-08-16 | EYPT | Eyepoint Pharmaceuticals, Inc. | Lurker Nancy | Dir | P - Purchase | $7.88 | +3,173 | 224,524 | +1% | +$25,003 | ||||||
| D | 2024-08-15 | MTD | Mettler Toledo International Inc/ | Magloth Christian | Head of HR | S - Sale+OE | $1,422.97 | -1,000 | 734 | -58% | -$1,422,970 | |||||
2024-08-14 | LAB | Standard Biotools Inc. | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $1.59 | +1,200,000 | 71,786,109 | +2% | +$1,913,520 | ||||||
| D | 2024-08-15 | BRKR | Bruker Corp | Rosenthal Bob | Dir | S - Sale+OE | $63.14 | -4,684 | 30,963 | -13% | -$295,748 | |||||
2024-08-13 | QTRX | Quanterix Corp | Toloue Masoud | Pres, CEO | P - Purchase | $10.90 | +19,000 | 354,119 | +6% | +$207,100 | ||||||
| M | 2024-08-09 | LAB | Standard Biotools Inc. | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $1.62 | +1,575,408 | 70,586,109 | +2% | +$2,559,641 | |||||
| M | 2024-08-07 | LAB | Standard Biotools Inc. | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $1.61 | +1,069,562 | 69,010,701 | +2% | +$1,718,801 | |||||
| D | 2024-08-07 | MTD | Mettler Toledo International Inc/ | Vadala Shawn | CFO | S - Sale+OE | $1,401.00 | -250 | 4,843 | -5% | -$350,250 | |||||
2024-08-08 | RPID | Rapid Micro Biosystems, Inc. | Malloy Kirk | Dir | P - Purchase | $0.91 | +50,000 | 64,300 | +350% | +$45,335 | ||||||
2024-08-07 | RPID | Rapid Micro Biosystems, Inc. | Wirtjes Sean M | CFO | P - Purchase | $0.78 | +10,000 | 348,157 | +3% | +$7,800 | ||||||
2024-08-07 | RVTY | Revvity, Inc. | Goldberg Joel S | Please See Remarks | S - Sale | $117.86 | -3,500 | 97,109 | -3% | -$412,507 | ||||||
2024-08-06 | RPID | Rapid Micro Biosystems, Inc. | Kollender Richard S | Dir | P - Purchase | $0.77 | +65,000 | 96,718 | +205% | +$50,128 | ||||||
2024-08-06 | RPID | Rapid Micro Biosystems, Inc. | Spignesi Robert G. Jr. | Pres, CEO | P - Purchase | $0.77 | +50,000 | 540,012 | +10% | +$38,400 | ||||||
| M | 2024-08-02 | LAB | Standard Biotools Inc. | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $1.62 | +1,200,000 | 67,941,109 | +2% | +$1,948,680 | |||||
| M | 2024-07-30 | AVTR | Avantor, Inc. | Couturier Christophe | EVP, AMEA | S - Sale | $27.01 | -10,100 | 73,930 | -12% | -$272,800 | |||||
| D | 2023-12-13 | SCND | Scientific Industries Inc | Nicols John J | Dir | P - Purchase | $2.00 | +15,000 | 15,000 | New | +$30,000 | |||||
2024-07-26 | A | Agilent Technologies, Inc. | McDonnell Padraig | Pres, CEO | S - Sale | $140.00 | -1,958 | 26,076 | -7% | -$274,120 | ||||||
| A | 2024-07-23 | LCTC | Lifeloc Technologies, Inc | Kornelsen Vern D | CFO | P - Purchase | $3.80 | +45,620 | 2,065,319 | +2% | +$173,356 | |||||
2024-07-23 | LCTC | Lifeloc Technologies, Inc | Siecke Donald E. | Dir | P - Purchase | $3.80 | +78,057 | 538,352 | +17% | +$296,617 | ||||||
2024-07-23 | LCLC | Lifeloc Technologies, Inc | Edco Partners Lllp | Dir | P - Purchase | $3.80 | +210,000 | 2,065,319 | +11% | +$798,000 | ||||||
2024-07-23 | LCTC | Lifeloc Technologies, Inc | Kornelsen Vern D | CFO | P - Purchase | $3.80 | +45,620 | 2,006,288 | +2% | +$173,356 | ||||||
2024-07-23 | LCTC | Lifeloc Technologies, Inc | Kornelsen Michael | Dir | P - Purchase | $3.80 | +2,132 | 27,500 | +8% | +$8,102 | ||||||
| D | 2024-07-12 | EYPT | Eyepoint Pharmaceuticals, Inc. | Guyer David R | Dir | S - Sale+OE | $10.06 | -11,625 | 1,850 | -86% | -$116,995 | |||||
| D | 2023-12-19 | SCND | Scientific Industries Inc | Cox Christopher T | Dir | P - Purchase | $2.00 | +79,245 | 301,245 | +36% | +$158,490 | |||||
2024-06-18 | A | Agilent Technologies, Inc. | McDonnell Padraig | Pres, CEO | S - Sale | $135.00 | -1,958 | 28,034 | -7% | -$264,330 | ||||||
2024-06-14 | SEER | Seer, Inc. | Nishar Dipchand | Dir | S - Sale | $1.78 | -12,109 | 79,457 | -13% | -$21,512 | ||||||
2024-06-13 | HBIO | Harvard Bioscience Inc | Green James W | CEO | P - Purchase | $2.91 | +10,000 | 3,111,091 | 0% | +$29,100 | ||||||
2024-06-13 | BIOBI | Bio-Rad Laboratories, Inc. | Crowley Michael | EVP, GBL Commercial Operations | S - Sale | $281.91 | -369 | 6,573 | -5% | -$104,023 | ||||||
2024-06-13 | SCND | Scientific Industries Inc | Moore John A | Dir | P - Purchase | $1.47 | +16,300 | 414,590 | +4% | +$24,035 | ||||||
| D | 2024-06-11 | AKYA | Akoya Biosciences, Inc. | McKelligon Brian | Pres, CEO | S - Sale+OE | $2.08 | -7,500 | 224,733 | -3% | -$15,630 | |||||
2024-06-10 | A | Agilent Technologies, Inc. | Grau Dominique | SVP | S - Sale | $133.28 | -15,000 | 102,288 | -13% | -$1,999,262 | ||||||
2024-06-07 | RVTY | Revvity, Inc. | Goldberg Joel S | Please See Remarks | S - Sale | $110.46 | -4,000 | 100,609 | -4% | -$441,844 | ||||||
| D | 2024-06-06 | AKYA | Akoya Biosciences, Inc. | McKelligon Brian | Pres, CEO | S - Sale+OE | $2.01 | -7,500 | 224,733 | -3% | -$15,064 | |||||
2024-06-06 | HBIO | Harvard Bioscience Inc | Green James W | CEO | P - Purchase | $3.07 | +20,000 | 3,101,091 | +1% | +$61,400 | ||||||
| D | 2024-06-03 | A | Agilent Technologies, Inc. | McDonnell Padraig | Pres, CEO | S - Sale+OE | $130.00 | -1,958 | 29,992 | -6% | -$254,540 | |||||
| M | 2024-05-28 | ASTC | Astrotech Corp | Becker James Frank | Dir | P - Purchase | $9.67 | +2,034 | 16,121 | +14% | +$19,675 | |||||
2024-05-28 | WAT | Waters Corp /de/ | Fearon Richard H | Dir | P - Purchase | $332.90 | +1,000 | 1,653 | +153% | +$332,900 | ||||||
2024-05-23 | LAB | Standard Biotools Inc. | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $2.60 | +100,000 | 71,611,233 | 0% | +$260,000 | ||||||
2023-05-23 | ASTC | Astrotech Corp | Hinojosa Jaime | CFO | P - Purchase | $9.49 | +900 | 7,881 | +13% | +$8,541 | ||||||
2024-05-22 | TXG | 10X Genomics, Inc. | McAnear Justin J. | CFO | S - Sale | $24.30 | -2,936 | 146,203 | -2% | -$71,355 | ||||||
2024-05-22 | TXG | 10X Genomics, Inc. | Saxonov Serge | CEO | S - Sale | $24.30 | -4,877 | 1,126,358 | 0% | -$118,529 | ||||||
2024-05-22 | TXG | 10X Genomics, Inc. | Hindson Benjamin J. | See Remarks | S - Sale | $24.30 | -4,087 | 350,055 | -1% | -$99,329 | ||||||
| M | 2024-05-20 | LAB | Standard Biotools Inc. | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $2.57 | +600,000 | 71,511,233 | +1% | +$1,541,795 | |||||
2024-05-20 | PACB | Pacific Biosciences of California, Inc. | Farmer Michele | See Remarks | S - Sale | $2.03 | -5,275 | 211,941 | -2% | -$10,708 | ||||||
| D | 2024-05-20 | AXDX | Accelerate Diagnostics, Inc | Mertz Larry Michael | CTO | S - Sale+OE | $0.88 | -361 | 82,028 | 0% | -$318 | |||||
2024-05-21 | ASTC | Astrotech Corp | Wilkinson Thomas Wiley | Dir | P - Purchase | $9.50 | +1,109 | 20,862 | +6% | +$10,536 | ||||||
| D | 2024-05-16 | MTD | Mettler Toledo International Inc/ | Vadala Shawn | CFO | S - Sale+OE | $1,528.43 | -300 | 4,914 | -6% | -$458,528 | |||||
| M | 2024-05-15 | LAB | Standard Biotools Inc. | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $2.56 | +1,352,072 | 70,911,233 | +2% | +$3,455,544 | |||||
| D | 2024-05-14 | EYPT | Eyepoint Pharmaceuticals, Inc. | Guyer David R | Dir | S - Sale+OE | $12.65 | -11,625 | 5,550 | -68% | -$147,045 | |||||
| D | 2024-05-15 | WAT | Waters Corp /de/ | Kuebler Christopher A | Dir | S - Sale+OE | $361.64 | -4,000 | 14,716 | -21% | -$1,446,560 | |||||
| D | 2024-05-15 | MTD | Mettler Toledo International Inc/ | Keller Gerry | Head of Process Analytics | S - Sale+OE | $1,511.56 | -310 | 6 | -98% | -$468,584 | |||||
| DM | 2024-05-13 | MTD | Mettler Toledo International Inc/ | Vadala Shawn | CFO | S - Sale+OE | $1,475.20 | -2,030 | 4,914 | -29% | -$2,994,661 | |||||
| D | 2024-05-13 | MTD | Mettler Toledo International Inc/ | Salice Thomas P | Dir | S - Sale+OE | $1,490.18 | -1,268 | 53,590 | -2% | -$1,889,551 | |||||
| D | 2024-05-13 | MTD | Mettler Toledo International Inc/ | Magloth Christian | Head of HR | S - Sale+OE | $1,470.97 | -1,100 | 734 | -60% | -$1,618,067 | |||||
2024-05-14 | QTRX | Quanterix Corp | Olson Laurie J | Dir | S - Sale | $16.98 | -1,500 | 13,738 | -10% | -$25,470 | ||||||
2024-05-06 | EYPT | Eyepoint Pharmaceuticals, Inc. | Cormorant Asset Management, LP | 10% | P - Purchase | $11.86 | +850,000 | 8,325,000 | +11% | +$10,081,721 | ||||||
2023-05-03 | BIOBI | Bio-Rad Laboratories, Inc. | Schwartz Steven D | 10% | S - Sale | $463.86 | -320 | 4,461,824 | 0% | -$148,435 | ||||||
2024-04-19 | CTKB | Cytek Biosciences, Inc. | Yan Ming | CTO | S - Sale | $5.87 | -20,000 | 5,988,502 | 0% | -$117,400 | ||||||
2024-04-18 | EYPT | Eyepoint Pharmaceuticals, Inc. | Cormorant Asset Management, LP | 10% | P - Purchase | $18.03 | +581,765 | 7,475,000 | +8% | +$10,489,446 | ||||||
| D | 2024-04-17 | AXDX | Accelerate Diagnostics, Inc | Phillips Jack | CEO | S - Sale+OE | $0.78 | -26,735 | 162,919 | -14% | -$20,853 | |||||
| D | 2024-04-12 | AXDX | Accelerate Diagnostics, Inc | Phillips Jack | CEO | S - Sale+OE | $0.86 | -26,545 | 129,726 | -17% | -$22,829 | |||||
2024-04-09 | CTKB | Cytek Biosciences, Inc. | Yan Ming | CTO | S - Sale | $7.00 | -1,900 | 6,008,502 | 0% | -$13,304 | ||||||
| D | 2024-04-09 | AXDX | Accelerate Diagnostics, Inc | Patience David | CFO | S - Sale+OE | $0.87 | -13,296 | 51,179 | -21% | -$11,568 | |||||
| D | 2024-04-09 | AXDX | Accelerate Diagnostics, Inc | Mertz Larry Michael | CTO | S - Sale+OE | $0.87 | -13,984 | 81,106 | -15% | -$12,166 | |||||
| D | 2024-04-04 | AXDX | Accelerate Diagnostics, Inc | Mertz Larry Michael | CTO | S - Sale+OE | $0.88 | -978 | 54,457 | -2% | -$861 | |||||
| D | 2024-04-04 | AXDX | Accelerate Diagnostics, Inc | Phillips Jack | CEO | S - Sale+OE | $0.88 | -15,887 | 96,343 | -14% | -$13,981 | |||||
| D | 2024-04-01 | QTRX | Quanterix Corp | Olson Laurie J | Dir | S - Sale+OE | $23.50 | -1,000 | 15,238 | -6% | -$23,500 | |||||
2024-03-25 | A | Agilent Technologies, Inc. | Binns Philip | SVP | S - Sale | $147.54 | -2,827 | 9,997 | -22% | -$417,096 | ||||||
| D | 2024-03-20 | AKYA | Akoya Biosciences, Inc. | McKelligon Brian | Pres, CEO | S - Sale+OE | $4.97 | -7,500 | 231,868 | -3% | -$37,243 | |||||
| AD | 2024-03-13 | AKYA | Akoya Biosciences, Inc. | McKelligon Brian | Pres, CEO | S - Sale+OE | $4.94 | -7,500 | 231,868 | -3% | -$37,043 | |||||
| M | 2024-03-18 | CTKB | Cytek Biosciences, Inc. | Yan Ming | CTO | S - Sale | $6.74 | -40,000 | 6,010,402 | -1% | -$269,600 | |||||
2024-03-15 | ASTC | Astrotech Corp | Russler Daniel T Jr | Dir | P - Purchase | $8.42 | +387 | 14,904 | +3% | +$3,259 | ||||||
2023-03-15 | ASTC | Astrotech Corp | McFarland Robert N | Dir | P - Purchase | $8.50 | +1,185 | 10,900 | +12% | +$10,073 | ||||||
| M | 2024-03-13 | ASTC | Astrotech Corp | Becker James Frank | Dir | P - Purchase | $8.20 | +1,488 | 14,087 | +12% | +$12,200 | |||||
2024-03-13 | AKYA | Akoya Biosciences, Inc. | McKelligon Brian | Pres, CEO | S - Sale | $4.94 | -7,500 | 224,368 | -3% | -$37,035 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |